ADVERTISEMENT
Aparna Nathan, PhD

Aparna Nathan, PhD

Aparna is a freelance science writer pursuing a PhD in bioinformatics and genomics at Harvard University. She uses her multidisciplinary training to find both the cutting-edge science and the human stories in everything from genetic testing to space expeditions. She was recently a 2021 AAAS Mass Media Fellow at the Philadelphia Inquirer. Her writing has also appeared in Popular Science, PBS NOVA, and The Open Notebook.

Articles by Aparna Nathan, PhD
ConPlex predicts what proteins a drug is likely to bind, which can help identify new targets for existing drugs.
Simplifying the Search for Drug Targets
Aparna Nathan, PhD | Aug 1, 2023 | 3 min read
A new machine learning model promises fast prediction of drug-target interactions.
iStock
Turning up the Heat on Brain Tumors
Aparna Nathan, PhD | Jul 17, 2023 | 3 min read
Oncolytic viruses can help glioblastoma respond to immunotherapy.
Scientist pipetting at the bench in white coat and purple gloves
Chek-Mate for Gliomas
Aparna Nathan, PhD | May 22, 2023 | 3 min read
New research may make immunotherapy possible for hard-to-treat brain tumors.
Abstract Genetics Disease stock photo
Bridging Disciplines to Study CRISPR-Induced Chromosome Destabilization
Aparna Nathan, PhD | Apr 8, 2022 | 4 min read
A collaboration between friends led to a cautionary finding about CRISPR’s effect on cells.
Engineered Bacteria Make Tumors More T Cell-Friendly
Engineered Bacteria Make Tumors More T Cell-Friendly
Aparna Nathan, PhD | Apr 8, 2022 | 5 min read
Microbes designed to produce specific immunomodulatory metabolites could give immunotherapy a boost.
Erika More developed a jello-like tissue system to study how immune cells stimulate tissues and blood vessel growth.
An Engineer’s Perspective on Autoimmunity
Aparna Nathan, PhD | Dec 10, 2021 | 4 min read
Erika Moore builds biomaterials to study disparate lupus outcomes.
Christmas background
Helping the Immune System Keep its Cool
Aparna Nathan, PhD | Dec 10, 2021 | 3 min read
Researchers found that lowering the temperature alleviates autoimmunity in mice.
800x560 istock image
Training Immune Cells to Be Cancer Killers
Aparna Nathan, PhD | Nov 12, 2021 | 4 min read
A career-altering experience as a cancer patient motivated one researcher to design more potent immunotherapies.
istock image 800x560
Can mRNA Vaccine Momentum Propel Tumor Immunotherapies?
Aparna Nathan, PhD | Nov 12, 2021 | 4 min read
A guide to mRNA-based cancer vaccines and where they’re headed next
istock-845814134-800x560
Early Successes Make CRISPR-Based Medicine a Possibility
Aparna Nathan, PhD | Oct 25, 2021 | 4 min read
CRISPR-Cas9’s molecular scissors—thus far limited to the lab bench—may soon find themselves at work directly in the human body.
ADVERTISEMENT
ADVERTISEMENT